Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis
CRD SUMMARY: This review assessed the effectiveness of antithrombotic agents in preventing central venous catheter-related thrombosis. The authors concluded that the limited evidence suggested that heparin did not significantly reduce thrombosis in patients receiviThis review assessed second-generation cholinesterase inhibitors for Alzheimer's disease. The authors concluded that, compared with placebo, cholinesterase inhibitors significantly improve the therapeutic effect and increase adverse events. The conclusions are likely to be reliable, but the variation in the studies must be borne in mind.
